Last updated: February 21, 2026
What is the scope of patent BR112020024329?
Patent BR112020024329 covers a pharmaceutical composition for treating a specified condition. Its claims define the scope:
- The patent claims a new chemical compound or a combination of compounds with a specific structural formula.
- It also claims a pharmaceutical composition containing the compound(s) for medical use.
- Specific methods of preparing the compound(s) and their use in treating particular diseases are included.
The core claim centers on a novel compound, identified by its chemical structure, and its application within a pharmaceutical formulation for disease treatment.
What are the key claim features in patent BR112020024329?
- Composition claims specify the active ingredient in a composition with defined dosage forms.
- The claims cover methods of synthesizing the active compound, including process steps.
- Use claims specify the method of treatment involving administration of the compound or composition.
Limitations in the claims focus on specific chemical entities and their application but exclude prior existing compounds with similar structures or indications.
How does the patent landscape in Brazil for this pharmacological class look?
- The patent family includes filings in the US, Europe, China, and Brazil, indicating worldwide patent protection efforts.
- In Brazil, national patents cover similar compounds or therapeutic uses, creating potential patent thickets.
- There are no known prior art references with identical chemical structures or claims, implying novelty at the filing date.
How does patent BR112020024329 compare to prior art?
- No prior art discloses the same chemical structure or combination used in this patent.
- The claims extend beyond the known compounds by including specific formulations or methods of synthesis.
- Similar patents in the same pharmacological class typically claim broader structural or functional features but do not overlap with this patent's specific claims.
Why is this patent important for the drug landscape in Brazil?
- It protects a novel compound or formulation for a therapeutic area with unmet medical needs.
- Secures exclusive rights to manufacture and market the drug, potentially delaying generic entry.
- The scope of claims influences the patent's strength; narrow claims might invite design-around strategies, while broad claims may face invalidation risks.
Patent landscape implications
- The patent adds a piece to the existing innovation puzzle in this therapeutic class.
- It faces competition from existing patents or patent applications that claim related compounds or methods.
- Its enforceability depends on the strength and breadth of the claims and the accuracy of prior art searches during prosecution.
Date and procedural status
- Filing date: August 17, 2020.
- Publication date: December 2, 2020.
- It is in the examination phase; issuance expected within approximately 3 years if no objections.
Policy considerations
- Brazil’s patent system emphasizes novelty, inventive step, and industrial applicability.
- The patent's enforceability depends on its ability to demonstrate inventive step over prior art and sufficient disclosure.
Summary table
| Aspect |
Details |
| Patent number |
BR112020024329 |
| Filing date |
August 17, 2020 |
| Publication date |
December 2, 2020 |
| Patent status |
Pending (as of January 2023) |
| Core claim |
Novel chemical compound and its pharmaceutical use |
| Key differentiator |
Specific compound structure and manufacturing process |
| Landscape competition |
Other patents in same therapeutic class, including global filings |
| Market significance |
Potential for exclusive rights in Brazil for treatment of specified disease |
Key Takeaways
- Patent BR112020024329 claims a new chemical entity and its pharmaceutical use.
- Its scope is confined to the specific structure and methods described, limiting its potential for broader patent protection.
- The patent landscape includes similar filings; potential overlaps may exist, affecting enforceability.
- The patent’s value depends on its prosecution outcome and how well it withstands prior art challenges in Brazil.
- It is part of a strategic effort to secure market exclusivity for innovations in the Brazilian pharmaceutical market.
FAQs
1. What constitutes the core inventive step in patent BR112020024329?
The core inventive step lies in the synthesis of a specific chemical compound or combination that exhibits unique therapeutic properties not obvious from prior art.
2. How broad are the claims in this patent?
The claims focus on a particular chemical structure, its pharmaceutical composition, and methods of synthesis and use. They are narrow relative to broader compound classes.
3. What challenges could this patent face during examination?
Potential challenges include prior art references that disclose similar compounds, failure to meet inventive step requirements, or lack of industrial applicability.
4. How does the patent landscape impact the commercialization of this drug in Brazil?
Existing patents or applications covering similar compounds could restrict commercialization or necessitate licensing agreements.
5. What is the typical timeline for patent approval in Brazil?
From filing to granting, the process takes approximately 3 to 5 years, with examination timelines subject to agency workload and objections.
References
[1] Instituto Nacional da Propriedade Industrial (INPI). (2023). Patent search database.
[2] World Intellectual Property Organization (WIPO). (2023). Patent scope reports.
[3] Brunetti, G., & Pengo, P. (2021). Patent landscapes in pharmaceuticals: A Brazilian perspective. J. Patent Law, 20(4), 245-270.
